Coronary interventions Five-year safety and performance data of a novel third-generation novolimus-eluting bioresorbable scaffold in single de novo lesions Verheye S, Costa R, Schofer J, Ormiston J, Maeng M, Dudek D, Skurk C, Botelho R, Costa J, Chamié D, Abizaid An, Boersma E, Abizaid A October 18, 2019 | 10.4244/EIJ-D-18-00292
Coronary interventions Relation between bioresorbable scaffold sizing using QCA-Dmax and long-term clinical outcomes in 1,232 patients from three study cohorts (ABSORB Cohort B, ABSORB EXTEND, and ABSORB II) Katagiri Y, Onuma Y, Asano T, Chichareon P, Collet C, Miyazaki Y, Piek J, Wykrzykowska J, Abizaid A, Ormiston J, Chevalier B, Serruys P October 12, 2018 | 10.4244/EIJ-D-18-00301
Stable CAD Long-term clinical outcomes of a crystalline sirolimus-eluting coronary stent with a fully bioabsorbable polymer coating: five-year outcomes from the DESSOLVE I and II trials Wijns W, Vrolix M, Verheye S, Schoors D, Slagboom T, Gosselink M, Benit E, Kandzar D, Donohoe D, Ormiston J April 6, 2018 | 10.4244/EIJ-D-17-00230
Bench testing and coronary artery bifurcations: a consensus document from the European Bifurcation Club Ormiston J, Kassab G, Finet G, Chatzizisis Y, Foin N, Mickley T, Chiastra C, Murasato Y, Hikichi Y, Wentzel J, Darremont O, Iwasaki K, Lefèvre T, Louvard Y, Beier S, Hojeibane H, Netravali A, Wooton J, Cowan B, Webster M, Medrano-Gracia P, Stankovic G February 2, 2018 | 10.4244/EIJ-D-17-00270
Coronary interventions Change in lumen eccentricity and asymmetry after treatment with Absorb bioresorbable vascular scaffolds in the ABSORB cohort B trial: a five-year serial optical coherence tomography imaging study Suwannasom P, Sotomi Y, Asano T, Koon J, Tateishi H, Zeng Y, Tenekecioglu E, Wykrzykowska J, Foin N, de Winter R, Ormiston J, Serruys P, Onuma Y April 7, 2017 | 10.4244/EIJ-D-16-00740
Coronary interventions DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial Iqbal J, Verheye S, Abizaid A, Ormiston J, De Vries T, Morrison L, Toyloy S, Fitzgerald P, Windecker S, Serruys P December 9, 2016 | 10.4244/EIJY15M10_04
Coronary interventions A computational atlas of normal coronary artery anatomy Medrano-Gracia P, Ormiston J, Webster M, Beier S, Young A, Ellis C, Wang C, Smedby O, Cowan B September 18, 2016 | 10.4244/EIJV12I7A139
Coronary interventions Evaluation of a crystalline sirolimus-eluting coronary stent with a bioabsorbable polymer designed for rapid dissolution: two-year outcomes from the DESSOLVE I and II trials Wijns W, Suttorp MJ, Zagozdzon L, Morice M, McClean D, Stella P, Donohoe D, Knape C, Ormiston J June 20, 2016 | 10.4244/EIJY15M09_14
Bioresorbable vascular scaffold treatment induces the formation of neointimal cap that seals the underlying plaque without compromising the luminal dimensions: a concept based on serial optical coherence tomography data Bourantas C, Serruys P, Nakatani S, Zhang Y-J, Farooq V, Diletti R, Ligthart J, Sheehy A, van Geuns R, McClean D, Chevalier B, Windecker S, Koolen J, Ormiston J, Whitbourn R, Rapoza R, Veldhof S, Onuma Y, Garcia-Garcia H November 20, 2015 | 10.4244/EIJY14M10_06
Coronary interventions Lessons from the real bench: non-BRS Ormiston J, Darremont O, Iwasaki K, Murasato Y, Hikichi Y, Webber B, Webster M May 19, 2015 | 10.4244/EIJV11SVA6
Coronary interventions Bioresorbable scaffolds on the bench Ormiston J, Motreff P, Darremont O, Webber B, Guérin P, Webster M May 19, 2015 | 10.4244/EIJV11SVA40
Coronary interventions The future of BRS in bifurcations Kraak R, Grundeken M.J, Onuma Y, Tu S, Wykrzykowska J, Chevalier B, Ormiston J, Serruys P May 19, 2015 | 10.4244/EIJV11SVA45
An independent bench comparison of two bioresorbable drug-eluting coronary scaffolds (Absorb and DESolve) with a durable metallic drug-eluting stent (ML8/Xpedition) Ormiston J, Webber B, Ben Ubod B, Darremont O, Webster M May 19, 2015 | 10.4244/EIJY15M02_03
Randomised study of a bioabsorbable polymer-coated sirolimus-eluting stent: results of the DESSOLVE II trial Wijns W, Vrolix M, Verheye S, Schoors D, Slagboom T, Gosselink M, Benit E, Donohoe D, Knape C, Attizzani G, Lansky A, Ormiston J April 20, 2015 | 10.4244/EIJY14M05_03
Coronary stent durability and fracture: an independent bench comparison of six contemporary designs using a repetitive bend test Ormiston J, Webber B, Ubod B, White J, Webster M April 20, 2015 | 10.4244/EIJY14M11_08
Early (before 6 months), late (6-12 months) and very late (after 12 months) angiographic scaffold restenosis in the ABSORB Cohort B trial Nakatani S, Onuma Y, Ishibashi Y, Muramatsu T, Iqbal J, Zhang Y-J, van Geuns R, Ormiston J, Serruys P March 20, 2015 | 10.4244/EIJV10I11A218
Circumferential distribution of the neointima at six-month and two-year follow-up after a bioresorbable vascular scaffold implantation: a substudy of the ABSORB Cohort B Clinical Trial Bourantas C, Farooq V, Zhang Y-J, Muramatsu T, Gogas B, Thuesen L, McClean D, Chevalier B, Windecker S, Koolen J, Ormiston J, Whitbourn R, Dorange C, Rapoza R, Onuma Y, Garcia-Garcia H, Serruys P March 20, 2015 | 10.4244/EIJY14M04_11
A Y-shaped bifurcation-dedicated stent for the treatment of de novo coronary bifurcation lesions: an IVUS analysis from the BRANCH trial Sakata K, Koo B, Waseda K, Nakatani D, Yock P, Whitbourn R, Worthley S, Ormiston J, Webster M, Wilkins G, Honda Y, Meredith I, Fitzgerald P March 20, 2015 | 10.4244/EIJY14M08_16
Absorb everolimus-eluting bioresorbable scaffolds in coronary bifurcations: a bench study of deployment, side branch dilatation and post-dilatation strategies Ormiston J, Webber B, Ubod B, Webster M, White J February 20, 2015 | 10.4244/EIJY14M05_08
New issue Antiplatelet strategies for complex PCI, are all DES equal at 10-year follow-up? cost-effectiveness of TAVR…find all the answers in the new issue (Intravascular lithotripsy (3.5 mm Shockwave; left), followed by balloon dilatation (4.0 mm NC; right)) December 6, 2019
Trials Book Discover 5 new trials: GALILEO, CONDI-2/ERIC-PCI, EVOLUTE II-5 years, SCOPE and Excel 5 years (The Trials book is supported by Biotronik) December 13, 2019
Editorial 2019 – A leap year for valvular heart disease (Course directors PCR London Valves 2019) November 15, 2019